{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:37:04Z","timestamp":1787996224946,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2019.01.021","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:36:21Z","timestamp":1548329781000},"page":"1126-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vaccination-associated acute disseminated encephalomyelitis"],"prefix":"10.1016","volume":"37","author":[{"given":"Hiroyuki","family":"Torisu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.01.021_b0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","article-title":"Incidence of acquired demyelination of the CNS in Canadian children","volume":"72","author":"Banwell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2019.01.021_b0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.inf.0000133048.75452.dd","article-title":"Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features","volume":"23","author":"Leake","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.01.021_b0015","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00415-012-6441-6","article-title":"Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study","volume":"259","author":"Ketelslegers","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.vaccine.2019.01.021_b0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2458-14-111","article-title":"Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: a retrospective study","volume":"14","author":"Xiong","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.01.021_b0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM198702123160703","article-title":"Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination","volume":"316","author":"Hemachudha","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.01.021_b0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2019.01.021_b0035","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nri2190","article-title":"The origin and application of experimental autoimmune encephalomyelitis","volume":"7","author":"Baxter","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.01.021_b0040","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.021_b0045","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1016\/j.vaccine.2010.02.053","article-title":"Evaluating the Brighton Collaboration case definitions, aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis, by systematic analysis of 255 clinical cases","volume":"28","author":"Rath","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.021_b0050","first-page":"S7","article-title":"Consensus definitions proposed for pediatric multiple sclerosis and related disorders","volume":"68","author":"Krupp LB, Banwell B, Tenembaum S, International Pediatric MSSG","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2019.01.021_b0055","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.vaccine.2019.01.021_b0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00431-006-0249-2","article-title":"Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey","volume":"166","author":"Pohl","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.021_b0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","article-title":"Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children","volume":"77","author":"Langer-Gould","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2019.01.021_b0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1352458512445944","article-title":"Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features","volume":"19","author":"Absoud","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.vaccine.2019.01.021_b0075","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.braindev.2009.10.006","article-title":"Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan","volume":"32","author":"Torisu","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.vaccine.2019.01.021_b0080","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1212\/WNL.0000000000003318","article-title":"A nationwide survey of pediatric acquired demyelinating syndromes in Japan","volume":"87","author":"Yamaguchi","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.021_b0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.pediatrneurol.2015.08.020","article-title":"Nationwide incidence of acquired central nervous system demyelination in icelandic children","volume":"53","author":"Gudbjornsson","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.vaccine.2019.01.021_b0090","unstructured":"Ministry of Health, Labour and Welfare: Yobou-sesshugo hukuhannnou houkokusyo syukei houkokusyo, URL: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/syukeihou.html [ref.2018.9.23]."},{"key":"10.1016\/j.vaccine.2019.01.021_b0095","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2006.05.130","article-title":"Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004","volume":"25","author":"Nakayama","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.021_b0100","doi-asserted-by":"crossref","first-page":"e77766","DOI":"10.1371\/journal.pone.0077766","article-title":"Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems","volume":"8","author":"Pellegrino","year":"2013","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:23Z","timestamp":1759401023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X19300751"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination-associated acute disseminated encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}